Makoto Yawata

Yawata Makoto

Appointment(s)
  • Assistant Professor, Department of Paediatrics
Joint Appointment(s)
  • Principal Investigator, Singapore Institute for Clinical Sciences, A*STAR
Academic Qualifications
  • PhD, Graduate School of Medicine, Yokohama City University, Japan
  • MD, School of Medicine, Yokohama City University, Japan
Research Interest(s)
  • Human Leukocyte Antigen
  • Natural Killer Cell
  • Myeloma
  • Haematology
Recent Publications
  • 1. Nemat-Gorgani, N., Hilton, H. G., Henn, B. M., Lin, M., Gignoux, C. R., Myrick, J. W., . . . Norman, P. J. (2018). Different Selected Mechanisms Attenuated the Inhibitory Interaction of KIR2DL1 with C2(+) HLA-C in Two Indigenous Human Populations in Southern Africa. JOURNAL OF IMMUNOLOGY, 200(8), 2640-2655. doi:10.4049/jimmunol.1701780
  • 2. Ichise, H., Nagano, S., Maeda, T., Miyazaki, M., Miyazaki, Y., Kojima, H., . . . Kawamoto, H. (2017). NK Cell Alloreactivity against KIR-Ligand-Mismatched HLA-Haploidentical Tissue Derived from HLA Haplotype-Homozygous iPSCs. STEM CELL REPORTS, 9(3), 853-867. doi:10.1016/j.stemcr.2017.07.020
  • 3. Yawata, N., Selva, K. J., Liu, Y. -C., Tan, K. P., Lee, A. W. L., Siak, J., . . . Yawata, M. (2016). Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection. MUCOSAL IMMUNOLOGY, 9(1), 159-170. doi:10.1038/mi.2015.47
  • 4. Lim, D. S. L., Yawata, N., Selva, K. J., Li, N., Tsai, C. Y., Yeong, L. H., . . . Wong, S. B. J. (2014). The Combination of Type I IFN, TNF-alpha, and Cell Surface Receptor Engagement with Dendritic Cells Enables NK Cells To Overcome Immune Evasion by Dengue Virus. JOURNAL OF IMMUNOLOGY, 193(10), 5065-5075. doi:10.4049/jimmunol.1302240
  • 5. Sharma, D., Bastard, K., Guethlein, L. A., Norman, P. J., Yawata, N., Yawata, M., . . . Parham, P. (2009). Dimorphic Motifs in D0 and D1+D2 Domains of Killer Cell Ig-Like Receptor 3DL1 Combine to Form Receptors with High, Moderate, and No Avidity for the Complex of a Peptide Derived from HIV and HLA-A*2402. JOURNAL OF IMMUNOLOGY, 183(7), 4569-4582. doi:10.4049/jimmunol.0901734